Literature DB >> 2384035

Hepatitis and augmentin.

K R Reddy, E R Schiff.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2384035     DOI: 10.1007/bf01537255

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  6 in total

1.  Cholestatic hepatitis after therapy with amoxicillin/clavulanate potassium.

Authors:  J E Schneider; M S Kleinman; J W Kupiec
Journal:  N Y State J Med       Date:  1989-06

2.  [Cholestatic hepatitis caused by a combination of amoxicillin and clavulanic acid (Augmentin)].

Authors:  J W van den Broek; B L Buennemeyer; B H Stricker
Journal:  Ned Tijdschr Geneeskd       Date:  1988-08-06

3.  Cholestatic hepatitis due to an amoxycillin/clavulanic acid preparation.

Authors:  M Verhamme; C Ramboer; P Van de Bruaene; N Inderadjaja
Journal:  J Hepatol       Date:  1989-09       Impact factor: 25.083

4.  Amoxicillin-clavulanate potassium-associated cholestasis.

Authors:  K R Reddy; P Brillant; E R Schiff
Journal:  Gastroenterology       Date:  1989-04       Impact factor: 22.682

5.  Amoxycillin/clavulanic acid (Augmentin)-induced intrahepatic cholestasis.

Authors:  J F Dowsett; T Gillow; A Heagerty; M Radcliffe; R Toadi; I Isle; R C Russell
Journal:  Dig Dis Sci       Date:  1989-08       Impact factor: 3.199

6.  Cholestatic hepatitis due to antibacterial combination of amoxicillin and clavulanic acid (augmentin)

Authors:  B H Stricker; J W Van den Broek; J Keuning; W Eberhardt; H G Houben; M Johnson; A P Blok
Journal:  Dig Dis Sci       Date:  1989-10       Impact factor: 3.199

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.